SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
opioid epidemic
opioid epidemic
Finance
All 50 states agree to OxyContin maker Purdue Pharma’s plan for Sackler family to pay up to $7 billion to settle opioid epidemic lawsuits
By
Geoff Mulvihill
and
The Associated Press
June 18, 2025
Finance
Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By
Geoff Mulvihill
and
The Associated Press
March 19, 2025
Politics
Canada appoints former Mountie as fentanyl czar as part of deal with Trump to avoid 25% tariffs
By
The Associated Press
February 12, 2025
Health
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By
Bloomberg
and
Gerry Smith
January 31, 2025
Health
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By
Geoff Mulvihill
and
The Associated Press
January 24, 2025
Health
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By
Julie Carr Smyth
and
The Associated Press
December 11, 2024
Health
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By
Andrew DeMillo
and
The Associated Press
June 25, 2024
Finance
Mexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia
By
The Associated Press
April 24, 2024
Health
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By
Geoff Mulvihill
and
The Associated Press
February 2, 2024
Health
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By
Lindsay Whitehurst
and
The Associated Press
February 1, 2024
Finance
Supreme Court justices agonize over Purdue Pharma settlement that would let Sackler family walk away with billions: ‘There is no other deal’
By
Mark Sherman
and
The Associated Press
December 5, 2023
Finance
OxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By
Mark Sherman
and
The Associated Press
December 4, 2023
Finance
Rite Aid files for bankruptcy in the face of massive debts and ‘potentially significant’ claims for its role in the opioid epidemic
By
Amelia Pollard
,
Ameya Karve
and
Bloomberg
October 16, 2023
Finance
Biden administration announces sweeping legal actions against Chinese fentanyl chemical producers
By
Fatima Hussein
,
Eric Tucker
and
The Associated Press
October 4, 2023
Magazine
As the opioid epidemic worsens, recovery-friendly policies are the next frontier in workplace inclusion
By
Erika Fry
July 27, 2023
Most Popular
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg